Kevin P. Siu
The Federal Court has clarified when parties can file new…
Read More
ai biologics biosimilars class actions competition copyright evidence fair dealing legislation methods of medical treatment overbreadth patentable subject matter patents pharmaceuticals privacy procedure regulatory TPMs trademarks